SCHEMBL31265017

SCHEMBL31265017

Cc1c(Cl)nnc2c1ncn2[C@@H]1CCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.44
PIK3CD O00329 3/20 0.41
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
SRC P12931 5/20 0.40
EGFR P00533 3/20 0.40
HPGDS O60760 1/20 0.39
FPR2 P25090 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
ADORA1 P30542 1/20 0.37
ABL1 P00519 2/20 0.37
ABL2 P42684 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269427 0.83 PIK3CD (0.43) HCAR1PIK3CDSRCEGFRCCNA2
SCHEMBL17143823 0.83 HCAR1 (0.45) HCAR1PIK3CDJAK2JAK1SRC
SCHEMBL17144495 0.83 HCAR1 (0.45) HCAR1PIK3CDJAK2JAK1SRC
SCHEMBL17143824 0.83 HCAR1 (0.45) HCAR1PIK3CDJAK2JAK1SRC
SCHEMBL30973451 0.82 HCAR1 (0.40) HCAR1PIK3CDJAK2JAK1SRC
SCHEMBL30994255 0.81 HCAR1 (0.49) HCAR1PIK3CDJAK2JAK1SRC
SCHEMBL30973548 0.81 SRC (0.42) HCAR1SRCEGFRHPGDSFPR2
SCHEMBL17546015 0.79 CYP1A2 (0.56) PIK3CDSRCEGFRADORA1ABL1
SCHEMBL31265006 0.79 IL1B (0.44) HCAR1JAK2JAK1SRCEGFR
SCHEMBL30973419 0.78 HTR6 (0.38) JAK2JAK1ADORA1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024249539-A1 5,6 UNSATURATED BICYCLIC HETEROCYLES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 MERCK SHARP & DOHME LLC (US) 2024-12-05 WO disclosed
US-20240400571-A1 5,6 UNSATURATED BICYCLIC HETEROCYLES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 MERCK SHARP & DOHME LLC (US) 2024-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400571-A1 5,6 UNSATURATED BICYCLIC HETEROCYLES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 NOD1, NLRP3, FABP3 HCAR1 14/4885PIK3CD 4403/4885JAK2 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.